Mjali, A.; Obaid, M.; Matti, B.; Abbas, N. Treatment Outcomes of Nilotinib As Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq. apjcc 2022, 7, 267-272.